Scleroderma, Systemic: Clinical Trials

8 trials for Scleroderma, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown. 8 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Unknown 8
Phase 25Unknown 5

Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Subcutaneous Semaglutide in Systemic Scleroderma
Semaglutide Pen Injector - Scleroderma, Systemic, Fibrosis
Phase 1UnknownSecond Xiangya Hospital of Central South University102024-02-292024-03-05
Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis
Topical 25% sodium metabisulfite (SM) in pediatric cold cream, Placebo - Systemic Sclerosis, Calcinosis
Phase 1 / Phase 2UnknownPontificia Universidad Catolica de Chile202024-01-022023-12-04
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
CD19-CAR-DNT cells - Systemic Lupus Erythematosus, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase 1UnknownRenJi Hospital482023-10-302024-03-18
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
CD19 targeted CAR-T cells - SLE (Systemic Lupus), Sjogren's Syndrome
Phase 1UnknownChongqing Precision Biotech Co., Ltd242023-08-312023-09-28
Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells
Autologous Regulatory Т-cells, Standard treatment according to the clinical protocols - Systemic Sclerosis
Phase 1 / Phase 2UnknownInstitute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus302022-09-012022-09-14
Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon
Neovasculgen - Secondary Raynaud's Phenomenon
Phase 1 / Phase 2UnknownArtgen Biotech302015-03-012015-02-05
Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study
Cutaneous iontophoresis of treprostinil - Scleroderma, Systemic
Phase 1 / Phase 2UnknownUniversity Hospital, Grenoble402012-02-012013-07-18
Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)
Allogeneic Mesenchymal Stem Cells (AlloMSC) - Systemic Sclerosis, Mesenchymal Stem Cells
Phase 1 / Phase 2UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School202009-08-012009-08-20

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Lupus Erythematosus, Systemic (2)  ·  Calcinosis (1)  ·  Dermatomyositis (1)  ·  Fibrosis (1)  ·  Myositis (1)  ·  Raynaud Disease (1)  ·  Scleroderma, Diffuse (1)  ·  Sjogren's Syndrome (1)

Broader conditions

Connective Tissue Diseases (8)  ·  Skin Diseases (8)  ·  Skin and Connective Tissue Diseases (8)  ·  Cardiovascular Diseases (3)  ·  Skin Diseases, Vascular (3)  ·  Vascular Diseases (3)  ·  Autoimmune Diseases (2)  ·  Immune System Diseases (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Systemic Vasculitis (2)  ·  Vasculitis (2)  ·  Arthritis (1)

Interventions

Cyclophosphamide (1)  ·  fludarabine (1)  ·  sodium metabisulfite (1)

Sponsors

Artgen Biotech (1)  ·  Chongqing Precision Biotech Co., Ltd (1)  ·  Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  RenJi Hospital (1)  ·  Second Xiangya Hospital of Central South University (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)  ·  University Hospital, Grenoble (1)

Countries

China (4)  ·  Belarus (1)  ·  Chile (1)  ·  France (1)  ·  Russia (1)

Top investigators

Andrei Hancharou, Dr (1)  ·  Antonia Valenzuela, MD, MS (1)  ·  Hao Ren, MD (1)  ·  Jean-Luc Cracowski, MD (1)  ·  Kanstantsin Chyzh, Dr (1)  ·  Ke Chai, MD (1)  ·  Licong Liu, MD (1)  ·  Liyun Zhang, M.D (1)  ·  Rong Xiao, MD (1)  ·  Ruixuan Zhu, MD (1)  ·  Xiangning Qiu, MD (1)  ·  Yangfan Xiao, MD (1)  ·  Yaqian Shi, MD (1)  ·  Yi Wei, MD (1)  ·  Zhan Yi, MD (1)

Results publications

PMID 22542159, PMID 28387950, PMID 28724445, PMID 38206544